Advanced Heart and Vascular Institute of Hunterdon

What Advanced Heart and Vascular Institute of Hunterdon does

Advanced Heart and Vascular Institute of Hunterdon (AHVI) is a physician-owned cardiovascular and endovascular medical practice based in Flemington, New Jersey, founded by interventional cardiologist Dr. Andrey Espinoza. The practice delivers comprehensive cardiovascular care spanning diagnostic testing (echocardiography, vascular ultrasound, stress testing), interventional procedures performed in a physician-owned office-based lab (OBL) described as nearly the size of a hybrid surgical suite, and minimally invasive venous treatments through a dedicated sub-brand called The VEINS. AHVI also operates an active clinical research division, having served as a site principal investigator in over 50 clinical trials covering novel oral anticoagulants, lipid-lowering therapies, bioresorbable scaffolds, drug-coated balloons, and AI-enabled imaging. The practice maintains hospital affiliations with Hunterdon Medical Center and Morristown Medical Center (Atlantic Health System).

AHVI's core technology stack includes AI-powered coronary CT angiography analysis through a partnership with Cleerly Health, 3D echocardiography, and comprehensive vascular ultrasound. The practice is structured around three operating units: the main cardiology/endovascular practice, The VEINS (designated #1 vein center in the NJ/NY/PA tri-state area), and the Vascular Center of Excellence OBL. Dr. Espinoza holds triple board certification (Cardiovascular Disease, Interventional Cardiology, Endovascular Medicine) and serves in leadership roles across SCAI, the IAC Vein Center Board, and ACC committees.

The business model is fee-for-service medical practice revenue billed through insurance networks, Medicare, and patient co-pays, supplemented by sponsor payments for clinical trial participation as a site. GTM is physician-referral-driven with direct-to-patient acquisition via website, community seminars, telemedicine, and professional reputation. AHVI serves primarily adult cardiovascular patients in Hunterdon County and the broader tri-state region, with sub-segments including venous disease patients, clinical trial participants, and at-risk patients with diabetes or metabolic syndrome.

Name

Advanced Heart and Vascular Institute of Hunterdon

Legal name

Advanced Heart and Vascular Institute

Website

https://hunterdonheartandvascular.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

1–10 employees

Short description

AHVI is a physician-owned cardiovascular and endovascular medical practice in Flemington, NJ, led by Dr. Andrey Espinoza, providing interventional cardiology, office-based lab procedures, vein care, and clinical research services to adult cardiovascular patients in the tri-state region.

Ownership category

akta.pro rank

Product category

Cardiovascular Medical Practice

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro industry

PRIMARYHLAFABAK

Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based)

Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers

SECONDARYHLAKABAE

Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear)

Healthcare & Life Sciences/Specialist Medical Practice/Cardiology & Vascular Medicine

SECONDARYHLAHAFAI

Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

Keywords

• Cardiovascular medical practice
• Interventional cardiology services
• Venous disease treatment
• Vascular diagnostic imaging
• Clinical research trials

Headquarters

HQ city

Flemington

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Clinical Services Revenue: Fee-for-service medical practice revenue generated from patient consultations, diagnostic tests, and interventional cardiovascular procedures performed in the office-based lab and affiliated hospitals. Services are billed through insurance, Medicare, and patient co-pays.
2. Clinical Trial Participation: Revenue from participating in pharmaceutical and device clinical trials as a site principal investigator. Study-related care provided at no cost to participants; sponsor funding covers research coordination and procedures.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Advanced Heart and Vascular Institute of Hunterdon (AHVI) is a physician-owned cardiovascular and endovascular medical practice providing comprehensive heart and vascular care, including diagnostic testing, interventional procedures, venous disease treatments, and clinical research. The practice operates an office-based lab and telemedicine visits, and runs a dedicated vein center (The VEINS) and an active clinical research division.

Product overview

Advanced Heart and Vascular Institute of Hunterdon (AHVI) is a cardiovascular and endovascular medical practice operating as a single unified practice with specialized divisions. The core offering centers on Dr. Andrey Espinoza's interventional cardiology and endovascular medicine services, supported by sub-brands including The VEINS (a dedicated venous disease center) and a Clinical Research Division conducting multiple trials. The practice offers a comprehensive range of cardiovascular diagnostic testing and treatments, including minimally invasive procedures, with access to advanced AI-powered imaging through clinical trial partnerships. Telemedicine video visits extend care accessibility, while an office-based lab (Vascular Center of Excellence) provides procedural capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• The VEINS: A dedicated vein center providing cutting-edge treatment methods for venous vascular disease, including Sclerotherapy, radiofrequency ablation, VenaSeal, and ambulatory phlebectomy.

Products and services

• Cardiovascular and Endovascular Medical Care Comprehensive heart and vascular care including diagnostic testing, medical management, and interventional procedures for coronary artery disease, heart failure, arrhythmias, valve disorders, hypertension, and peripheral arterial disease.
• The VEINS - Venous Endovascular Invasive Solutions A dedicated multi-specialty vein center providing diagnosis and treatment of venous vascular disease, including VenaSeal, radiofrequency ablation, sclerotherapy, and ambulatory phlebectomy. Recognized as the #1 vein center in the tri-state area.

Quantifiable outcome

• Fastest Door-to-Balloon times in New Jersey for heart attack treatment
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• Cleerly HealthcoreStrategic or Co-development PartnerSponsor of the TRANSFORM Trial investigating AI-enabled CCTA imaging for personalized cardiovascular risk assessment. AHVI serves as a clinical trial site using Cleerly's coronary artery disease staging system for early detection in patients with diabetes and metabolic syndrome.
• Avantec VascularminorStrategic or Co-development PartnerSponsor of the Golazo Peripheral Atherectomy System Study evaluating treatment of peripheral arterial disease. AHVI serves as a clinical trial site for this device study.
• Morristown Medical Center (Atlantic Health System)coreStrategic or Co-development PartnerHospital affiliation where Dr. Espinoza maintains privileges and collaborates on patient care. Dr. Espinoza has received Top Doctor recognition in partnership with Atlantic Health System.
• Hunterdon Medical CentercoreStrategic or Co-development PartnerPrimary hospital affiliation where Dr. Espinoza formerly served as Medical Director of Cardiac Catheterization Laboratory and Primary Angioplasty program. Dr. Espinoza led the development of the heart attack program achieving fastest Door-to-Balloon times in NJ.
• Duke Clinical Research InstituteminorStrategic or Co-development PartnerDr. Espinoza has worked with Duke Clinical as a site principal investigator contributing to cardiovascular clinical trials, including PCSK9 inhibitor research.
• Harvard Clinical Research InstituteminorStrategic or Co-development PartnerCollaboration with Harvard Clinical on cardiovascular research contributing to the advancement of cardiovascular medicine and drug approvals.
• National Institutes of Health (NIH)coreStrategic or Co-development PartnerDr. Espinoza has collaborated with NIH on clinical trials contributing to approvals of novel oral anti-thrombotic drugs and newer PCSK9 compounds for cholesterol reduction.
• Intersocietal Accreditation Commission (IAC) Vein CentercoreStrategic or Co-development PartnerDr. Espinoza was elected to the IAC Vein Center Board of Directors, committed to improving quality of vein disease treatment and management.
• Society for Cardiovascular Angiography & Interventions (SCAI)coreStrategic or Co-development PartnerDr. Espinoza served as lead author on 2025 SCAI Clinical Practice Guidelines for Management of Chronic Venous Disease, contributing to evidence-based guidelines for patients, clinicians, and stakeholders.
• American College of Cardiology (ACC)coreStrategic or Co-development PartnerDr. Espinoza is a Fellow of the ACC (FACC) and serves on the Peripheral Vascular Council and Cardio-Oncology division committees.
• American College of PhlebologyminorStrategic or Co-development PartnerProfessional membership organization for venous disease specialists; Dr. Espinoza is a member contributing to vein disease treatment standards.

Scale indicators5 records

Direct peers

• Vein Clinics of America: Established vein treatment clinic network offering sclerotherapy, RFA, and VenaSeal procedures. Closely comparable to The VEINS at AHVI in both procedural offerings and physician-led outpatient model.
• USA Vein Clinics: Multi-site outpatient vein center chain offering VenaSeal, RFA, and sclerotherapy. Directly comparable to AHVI's The VEINS sub-brand in service mix (minimally invasive venous disease treatment) and patient segment.
• Medicus Vein Care: Independent vein center offering minimally invasive treatments (VenaSeal, RFA, sclerotherapy). Comparable as a physician-led vein center competing in the same regional market for venous disease patients.

Broad incumbents

• Mount Sinai Heart (Icahn School of Medicine): Academic cardiology program within Mount Sinai Health System in New York. Comparable in offering comprehensive cardiovascular care including interventional and structural procedures, and in publishing clinical guidelines.
• Cleveland Clinic Heart, Vascular & Thoracic Institute: Top-ranked academic cardiovascular institute offering full-spectrum cardiology, interventional, and vascular services. Comparable as a high-volume, high-reputation cardiology provider though at substantially greater scale and academic orientation.
• Atlantic Health System Heart Care: Hospital-affiliated cardiovascular program within the Atlantic Health System, including Morristown Medical Center where Dr. Espinoza holds privileges. Comparable as a regional cardiology provider and existing hospital partner of AHVI.

Regional players

• New Jersey Cardiology Associates: Multi-physician cardiology group serving New Jersey with diagnostic, interventional, and electrophysiology services. Comparable regional cardiology specialty practice competing for similar patient demographics.
• Capital Cardiology Associates: Multi-site independent cardiology practice in the Northeast (NY capital region) with diagnostic, interventional, and OBL capabilities. Comparable independent cardiology group model with OBL and physician ownership structure.

Emerging players

• CardioOne: Tech-enabled cardiology practice management partner for independent cardiology groups. Comparable as a model for independent cardiology practices seeking infrastructure, payer contracting, and growth support.
• Cardiovascular Associates of America (CVAUSA): Cardiology practice consolidation platform backed by Webster Equity Partners, aggregating independent cardiology groups including OBL operators. Comparable as a cardiology practice model with OBL and clinical research orientation, though operating at platform scale.

Market position

Strengths5 records

Weaknesses5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/AHVImedicine
• LinkedInlinkedin.com/company/advanced-heart-and-vascular-institute-of-hunterdon

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Advanced Heart and Vascular Institute of Hunterdon